Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$165.67 - $199.94 $3,313 - $3,998
-20 Reduced 1.6%
1,233 $208,000
Q4 2023

Jan 31, 2024

BUY
$151.44 - $200.09 $6,360 - $8,403
42 Added 3.47%
1,253 $247,000
Q3 2023

Nov 02, 2023

SELL
$167.14 - $192.77 $29,249 - $33,734
-175 Reduced 12.63%
1,211 $210,000
Q2 2023

Jul 31, 2023

SELL
$160.94 - $186.23 $14,806 - $17,133
-92 Reduced 6.22%
1,386 $238,000
Q1 2023

Apr 26, 2023

SELL
$145.48 - $175.02 $21,676 - $26,077
-149 Reduced 9.16%
1,478 $245,000
Q4 2022

Jan 30, 2023

SELL
$131.14 - $157.47 $5,507 - $6,613
-42 Reduced 2.52%
1,627 $238,000
Q3 2022

Oct 18, 2022

SELL
$148.29 - $182.55 $15,867 - $19,532
-107 Reduced 6.02%
1,669 $247,000
Q2 2022

Jul 27, 2022

SELL
$155.97 - $200.09 $20,120 - $25,811
-129 Reduced 6.77%
1,776 $305,000
Q1 2022

Apr 29, 2022

SELL
$181.39 - $234.03 $42,808 - $55,231
-236 Reduced 11.02%
1,905 $359,000
Q4 2021

Feb 28, 2022

BUY
$193.69 - $247.03 $414,690 - $528,891
2,141 New
2,141 $522,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Echo45 Advisors LLC Portfolio

Follow Echo45 Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo45 Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo45 Advisors LLC with notifications on news.